Carcinogenicity and mechanism of action of fumonisin B1: A mycotoxin produced by Fusarium moniliforme (= F. verticillioides)

Cancer Detection and Prevention

Volumn 26, Issue 1, 2002, Pages 1-9

  Voss, Kenneth A ^a   Howard, Paul C ^b   Riley, Ronald T ^a   Sharma, Raghubir P ^c   Bucci, Thomas J ^d   Lorentzen, Ronald J ^e  

^a RUSSELL RESEARCH CENTER   (United States)

^b NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^c UNIVERSITY OF GEORGIA   (United States)

^d Pathology Associates International   (United States)

^e CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Carcinogenicity; Fumonisin B1; Fusarium moniliforme (= F. verticillioides); Sphingolipids; Tumor necrosis factor

Indexed keywords

CARCINOGEN; DIHYDROCERAMIDE DESATURASE; ENZYME INHIBITOR; FUMONISIN; FUMONISIN B1; MESSENGER RNA; MYCOTOXIN; OXIDOREDUCTASE; SPHINGOLIPID; SPHINGOSINE; TUMOR NECROSIS FACTOR RECEPTOR;

ADENOMA; ANIMAL; APOPTOSIS; ARTICLE; BIOSYNTHESIS; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; FEMALE; FISCHER 344 RAT; FUSARIUM; GENETICS; KIDNEY; KIDNEY TUMOR; LIVER; LIVER TUMOR; MALE; METABOLISM; MOUSE; MOUSE MUTANT; PATHOLOGY; RAT;

ADENOMA; ANIMALS; APOPTOSIS; CARCINOGENS, ENVIRONMENTAL; ENZYME INHIBITORS; FEMALE; FUMONISINS; FUSARIUM; KIDNEY; KIDNEY NEOPLASMS; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYCOTOXINS; OXIDOREDUCTASES; RATS; RATS, INBRED F344; RECEPTORS, TUMOR NECROSIS FACTOR; RNA, MESSENGER; SPHINGOLIPIDS; SPHINGOSINE;

EID: 0036947372     PISSN: 0361090X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-090X(02)00011-9     Document Type: Article

References (49)

1. Gelderblom WCA, Jaskiewicz K, Marasas WFO, et al. Fumonisins-novel mycotoxins with cancer promoting activity produced by Fusarium moniliforme. Appl Environ Microbiol 1988;54:1806-11.
2. 1 isolated from Fusarium moniliforme. Onderstepoort J Vet Res 1988;55:197-203.
3. 1. Onderstepoort J Vet Res 1990;57:269-75.
4. 1, a toxic metabolite of Fusarium moniliforme. J Vet Diagn Invest 1990;2:217-21.
5. Smith GW, Constable PD, Bacon CW, et al. Cardiovascular effects of fumonisins in swine. Fund Appl Toxicol 1996;31:169-72.
6. 1. International program on chemical safety. Environmental Health Criteria 219. Geneva: World Health Organization, 2000.
7. 1 as an example. Toxicol Sci 2001;61:6-17.
8. 1-treated male and female Sprague-Dawley rats. Cancer Lett 1998;128:31-9.
9. 1 dosimetry in relation to cancer initiation in rat liver. Carcinogenesis 1994;15:209-14.
10. Marasas WFO. Discovery and occurrence of the fumonisins: a historical perspective. Environ Health Persp 2001;109(Suppl 2):239-43.
11. Rheeder JP, Marasas WFO, Thiel PF, et al. Fusarium moniliforme and fumonisins in corn in relation to human esophageal cancer in Transkei. Phytopathol 1992;82:353-7.
12. Turner PC, Nikiema P, Wild CP. Fumonisin contamination of food: progress in the development of biomarkers to better assess human health risks. Mutat Res 1999;443:81-93.
13. Yang CS. Research on esophageal cancer in China: a review. Cancer Res 1980;40:2633-44.
14. Yoshizawa T, Yamashita A, Luo Y. Fumonisin occurrence in corn from high- and low-risk areas for human esophageal cancer in China. Appl Environ Microbiol 1994;60:1626-9.
15. 1 and other mycotoxins in moldy corn collected from the People's Republic of China in regions with high incidences of esophageal cancer. Appl Environ Microbiol 1994;60:847-52.
16. Marasas WFO, Kriek NPJ, Fincham JE, et al. Primary liver cancer and oesophageal basal cell hyperplasia in rats caused by Fusarium moniliforme. Int J Cancer 1984;34:383-7.
17. Jaskiewicz K, van Rensburg SJ, Marasas WFO, et al. Carcinogenecity of Fusarium moniliforme culture material in rats. J Natl Cancer Inst 1987;78:321-5.
18. 1 in rats. Carcinogenesis 1991;12:1247-51.
19. 1. Nat Toxins 1993;1:222-8.
20. Tolleson WH, Dooley KL, Sheldon WG, et al. The mycotoxin fumonisin induces apoptosis in cultured human cells and in livers and kidneys of rats. Adv Exp Med Biol 1996;392:237-50.
21. 1 mice and Fischer 344 rats. Fund Appl Toxicol 1995;24:102-10.
22. 1 in the F344/N/Nctr BR rat. Environ Health Persp 2001;109(Suppl 2):309-14.
23. 1 includes rare variants of renal tubule tumor. Toxicol Pathol 2001;29:379-86.
24. Wang E, Norred WP, Bacon CW, et al. Inhibition of sphingolipid biosynthesis by fumonisins. J Biol Chem 1991;266:14486-144490.
25. Yoo HS, Norred WP, Showker J, et al. Elevated sphingoid bases and complex sphingolipid depletion as contributing factors in fumonisin-induced cytotoxicity. Toxicol Appl Pharmacol 1996;138:211-8.
26. Riley RT, Enongene EN, Voss KA, et al. Sphingolipid perturbations as mechanisms for fumonisin carcinogenesis. Environ Health Persp 2001;109(Suppl 2):301-8.
27. Merrill Jr AH, Schmelz EM, Dillehay DL, et al. Sphingolipids-the enigmatic lipid class: biochemistry, physiology, and pathophysiology. Toxicol Appl Pharmacol 1997;142:208-25.
28. Liu G, Kleine L, Hébert RL. Advances in the signal transduction of ceramide and related sphingolipids. Crit Rev Clin Lab Sci 1999;36:511-73.
29. Bazzoni F, Beutler B. The tumor necrosis factor ligand and receptor families. New Engl J Med 1996;334:1717-25.
30. Bayeart R, Fiers W. Tumor necrosis factor and lymphotoxin. In: Miresluis A, Thorpe R, editors. Cytokines. New York: Academic Press, 1998. p. 335-60
31. 1 toxicity. J Pharmacol Exp Ther 1998;285:317-24.
32. 1 mice. Mycotoxins 1999;(Suppl 99):45-54.
33. 1 mice. Environ Health Persp 2001;109(Suppl 2):277-82.
34. 1 in New Zealand White rabbits. Fund Appl Toxicol 1997:40:120-8.
35. 1 induces disruption of sphingolipid metabolism in Sprague-Dawley rats: a new mechanism of nephrotoxicity. J Nutr 1994;124:594-603.
36. Sharma RP, Bhandari N, Riley RT, et al. Tolerance to fumonisin toxicity in a mouse strain lacking the P75 tumor necrosis factor receptor. Toxicology 2000;143:183-94.
37. Sharma RP, Bhandari N, He Q, et al. Decreased fumonisin hepatotoxicity in mice with a targeted deletion of tumor necrosis factor receptor 1. Toxicology 2001;159:69-79.
38. 1 toxicity in male Sprague-Dawley rats. Adv Exp Med Biol 1996;392:251-64.
39. Hunnan YA, Obeid LM. Ceramide: an intracellular signal for apoptosis. Trends Biochem Sci 1995;20:73-7.
40. Merrill Jr AH. Cell regulation by sphingosine and more complex sphingolipids. J Bioenerg Biomembr 1991;23:83-104.
41. Voss KA, Riley RT, Norred WP, et al. An overview of rodent toxicities: liver and kidney effects of fumonisins and Fusarium moniliforme. Environ Health Persp 2001;109(Suppl 2):259-66.
42. Goldsworthy TL, Conolly RB, Fransson-Steen R. Apoptosis and cancer risk assessment. Mutat Res 1996;365:71-90.
43. Majno G, Joris I. Apoptosis, oncosis, and necrosis: an overview of cell death. Am J Pathol 1995;146:3-15.
44. 1 in rat liver - role of cell proliferation. Cancer Lett 2001;169:127-37.
45. 1. J Comp Pathol 1997;117:371-81.
46. Digby MR, Kimpton WG, York JJ, et al. ITA, a verebrate homologue of IAP that is expressed in T-lymphocytes. DNA Cell Biol 1996;15:981-8.
47. 1: a mycotoxin contaminant of cereal grains, and inducer of apoptosis via the tumor necrosis factor pathway and caspase activation. Fd Chem Toxicol 1999;37:703-12.
48. Sharma RP, Bhandari N, Tsunoda M, et al. Fumonisin hepatotoxicity is reduced in mice carrying the human tumour necrosis factor α transgene. Arch Toxicol 2000;74:238-48.
49. Sharma RP, Bhandari N, He Q, et al. Unexpected fumonisin hepatotoxicity responses in transgenic mouse models lacking the tumor necrosis factor α pathways. Toxicol Sci 2001;60(Suppl):419.